<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03856021</url>
  </required_header>
  <id_info>
    <org_study_id>RI2019Shakked</org_study_id>
    <nct_id>NCT03856021</nct_id>
  </id_info>
  <brief_title>Microfracture vs. Microfracture and BMAC for Osteochondral Lesions of the Talus</brief_title>
  <official_title>Comparing Outcomes of Microfracture Versus Microfracture and Bone Marrow Aspirate Concentrate for the Treatment of Osteochondral Lesions of the Talus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteochondral lesions of the talus are thought to be due in large part to traumatic events or
      repetitive microtrauma that causes damage to both the articular cartilage and the subchondral
      bone. There are several treatment modalities for osteochondral lesions of the talus but there
      is no consensus as to which is the superior method for repair.

      Treatment modalities are aimed at regenerating articular cartilage. Microfracture is a widely
      accepted and utilized treatment for osteochondral lesions. This procedure results in
      pluripotent bone marrow stem cells filling the defect and ultimately differentiating into
      fibrocartilage-producing cells [1]. This technique has shown good results in both short- and
      medium-term follow-up for smaller lesions. Bone marrow aspirate contains mesenchymal stem
      cells and growth factors with cartilage regeneration potential. Bone marrow aspirate
      concentrate (BMAC) is a treatment modality that has shown to have to potential to produce
      hyaline cartilage. This study aims to analyze the effect of adding BMAC to the standard
      microfracture procedure in terms of clinical and radiographic outcomes in comparison to
      patients who only underwent microfracture treatment.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 18, 2018</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Foot and Ankle Ability Measure (FAAM)</measure>
    <time_frame>3 years following surgery</time_frame>
    <description>validated patient-reported outcome measure</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Osteochondral Lesion of Talus</condition>
  <arm_group>
    <arm_group_label>Microfracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Microfracture with Bone Marrow Aspirate Concentrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microfracture with Bone Marrow Aspirate Concentrate</intervention_name>
    <description>Bone Marrow Aspirate Concentrate harvested and prepared from the iliac crest</description>
    <arm_group_label>Microfracture with Bone Marrow Aspirate Concentrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microfracture</intervention_name>
    <description>All surgeons will use a 2 mm microfracture pick to perform the microfracture procedure. Using the 2 mm pick, surgeons will make 5 holes per 10 cm2.</description>
    <arm_group_label>Microfracture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Greater than 18 years of age and scheduled for surgery to treat osteochondral lesion of the
        talus Able and willing to sign informed consent document

        Exclusion Criteria:

        Unwilling to sign informed consent document
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 25, 2019</study_first_submitted>
  <study_first_submitted_qc>February 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2019</study_first_posted>
  <last_update_submitted>February 25, 2019</last_update_submitted>
  <last_update_submitted_qc>February 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

